Evexia Lifecare Stock Falls to 52-Week Low of Rs.1.52 Amidst Continued Downtrend

The stock has been on a losing streak for the past three consecutive days, registering a cumulative return of -2.3% during this period. Today's decline of -1.16% further extends this trend, with the stock underperforming its sector by approximately -1.2%. This movement contrasts with the broader market, where the Sensex advanced by 0.36%, closing at 84,978.48 points, just 0.37% shy of its own 52-week high of 85,290.06.

Evexia Lifecare’s current trading levels are below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a persistent bearish momentum. This technical positioning reflects the stock’s struggle to regain upward traction in the near term.

Over the last year, Evexia Lifecare’s stock has generated a return of -57.50%, a stark contrast to the Sensex’s 9.54% gain over the same period. The stock’s 52-week high was Rs.4.40, underscoring the extent of the decline to its current low. This performance also trails the BSE500 index across multiple time frames, including the last three years, one year, and three months.

From a fundamental perspective, the company’s long-term financial metrics reveal subdued growth and profitability. The net sales have shown a compound annual growth rate (CAGR) of -1.85% over the past five years, indicating a contraction in revenue generation. Profitability metrics further highlight challenges, with an average return on equity (ROE) of 0.88%, signalling limited returns on shareholders’ funds.

Debt servicing capacity appears constrained, as reflected by a Debt to EBITDA ratio of -1.00 times, suggesting the company’s earnings before interest, taxes, depreciation, and amortisation are insufficient relative to its debt obligations. This financial structure may contribute to the stock’s valuation pressures.

Recent quarterly results reinforce the subdued financial environment. The profit after tax (PAT) for the nine months ended September 2025 stood at Rs.1.31 crore, reflecting a decline of -66.50%. The quarterly profit before depreciation, interest, and taxes (PBDIT) reached a low of Rs.0.11 crore, while the operating profit to net sales ratio for the quarter was 0.43%, marking a trough in operational profitability.

Return on capital employed (ROCE) is reported at 0.1%, and the enterprise value to capital employed ratio stands at 0.9, indicating a valuation that may be considered expensive relative to the company’s capital base. However, the stock is trading at a discount compared to the average historical valuations of its peers within the edible oil sector.

Shareholding patterns indicate that the majority of Evexia Lifecare’s shares are held by non-institutional investors, which may influence liquidity and trading dynamics. The stock’s market capitalisation grade is rated at 4, reflecting its micro-cap status within the edible oil industry.

In comparison, the broader market environment remains positive, with the Sensex trading above its 50-day moving average, which itself is positioned above the 200-day moving average, a technical configuration often associated with bullish market conditions. Mega-cap stocks have been leading the market gains, contrasting with the performance of smaller-cap stocks such as Evexia Lifecare.

Overall, Evexia Lifecare’s stock has experienced a notable decline to its 52-week low of Rs.1.52, reflecting a combination of subdued financial performance, valuation considerations, and technical weakness. The stock’s underperformance relative to sector peers and broader market indices highlights the challenges faced by the company in recent periods.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →